FDA panel finds GE's imaging agent Datscan beneficial

08/11/2009 | Wall Street Journal, The

An FDA panel said GE Healthcare's Datscan, an imaging agent that helps identify neurological disorders, is safe to use in patients. Panel members said they would have preferred to have more information on whether the agent can pinpoint Parkinson's disease rather than only helping doctors localize it. The company plans to review data from patients who have used the product, an official said.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA